Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Fins on sedar

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Feb 29, 2024 5:39pm

284 Views

Post# 35907781

RE:RE:RE:RE:RE:RE:RE:Fins on sedar

Sales of raw ingredients always comes before a launch as it's sent to a manufacturing facility for production.

That is alot of kg purchased so my sense is that this is ramp up levels. Keep in mind R&F, last time I checked a month ago was still selling the Sirona active ingredient with the remaining product.

Thank god we got royalties this time around on net sales.

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks